Cited by 64

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Consistent immunohistochemical detection of intracellular β-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex

D'Andrea, Michael R., Nagele, Robert G., Wang, Hoau-Yan, Lee, Daniel H.S.·2002·Neuroscience Letters

Abstract

We compared the effects of three pretreatment immunohistochemical techniques (no pretreatment, pepsin predigestion and heat pretreatment (HEAT)) for detecting intracellular beta-amyloid42 (Abeta42) in pyramidal neurons of formalin-fixed Alzheimer's disease (AD) cortices (n = 25). Although all three protocols immunostained Abeta42 in amyloid plaques using four commercially-obtained Abeta42 specific antibodies, only the HEAT protocol consistently detected prominent intracellular Abeta42 in pyramidal neurons. This suggests that the Abeta42 present in amyloid plaques may be structurally distinct from that located within the neurons perhaps due to differential binding proteins coupling or a consequence of formalin fixation. Detection of an abundant intracellular Abeta42 in neurons may provide alternate explanations for the origin of dense-core amyloid plaques in AD cortices other than the conventional chronic extracellular Abeta42 deposition hypothesis.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0304-3940(02)00875-3

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intracellular accumulation of Aβ-(1-42) results from one or a combination of decreased Aβ degradation, increased intracellular generation of Aβ, and increased uptake of Aβ from an external source.

    “Intracellular accumulation of A␤-(1-42) results from one or a combination of the following processes: decreased A␤ degradation (disruption of the ubiquitin-proteasome system), increased intracellular generation of A␤, and increased uptake of A␤ from an external source (11).”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 14

  1. Bence, 2001, Impairment of the ubiquitin-proteasome system by protein aggregation, Science, 292, 1552, 10.1126/science.292.5521.1552 · DOI
  2. D'Andrea, 2002, MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in Alzheimer's disease brains, Biotec. Histochem., 77:2, 95, 10.1080/714028180 · DOI
  3. D'Andrea, 2002, Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains, Neurosci. Lett., 323, 45, 10.1016/S0304-3940(01)02444-2 · DOI
  4. D'Andrea, 2001, Application of triple-label immunohistochemistry to characterize inflammation in Alzheimer's disease brains, Biotec. Histochem., 76, 97, 10.1080/bih.76.2.97.106 · DOI
  5. Iwata, 2000, Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition, Nat. Med., 6, 143, 10.1038/77399 · DOI
  6. Iwata, 2001, Metabolic regulation of brain Aβ by neprilysin, Science, 292, 1550, 10.1126/science.1059946 · DOI
  7. Kraszpulski, 1998, Pitfalls in the quantitative estimation of β-amyloid immunoreactivity in human brain tissue, Histochem. Cell Biol., 110, 439, 10.1007/s004180050305 · DOI
  8. Levy, 2001, Codeposition of cystatin C with amyloid-β protein in the brain of Alzheimer disease patients, J. Neuropathol. Exp. Neurol., 60, 94, 10.1093/jnen/60.1.94 · DOI
  9. Nagele, 2002, Accumulation of beta-amyloid1-42 in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease, Neuroscience, 110, 199, 10.1016/S0306-4522(01)00460-2 · DOI
  10. Shi, 1997, Antigen retrieval immunohistochemistry: past, present, and future, J. Histochem. Cytochem., 54, 327, 10.1177/002215549704500301 · DOI
  11. Sparks, 1996, Intraneuronal β-amyloid immunoreactivity in the CNS, Neurobiol. Aging, 17, 291, 10.1016/0197-4580(95)02067-5 · DOI
  12. Taylor, 1994, Hum. Pathol., 25, 263, 10.1016/0046-8177(94)90198-8 · DOI
  13. Wang, 2000, β-amyloid1-42 binds to α7 nicotinic acetylcholine receptor with high affinity: implications for Alzheimer's disease pathology, J. Biol. Chem., 275, 5626, 10.1074/jbc.275.8.5626 · DOI
  14. Wirths, 2001, Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice, Neurosci. Lett., 306, 116, 10.1016/S0304-3940(01)01876-6 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
D'Andrea, M. R., Nagele, R. G., Wang, H.-Y., & Lee, D. H. S.
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2002-11
Volume
333
Issue
3
Pages
163-166
ISSN
0304-3940
Cited by
64
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review